Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-04 Sale |
2025-02-12 4:05 pm |
HilleVax Inc. | HLVX | HERSHBERG ROBERT See Remarks |
26,535 | $1.8338 | $48,661 | 1,101,498 (Direct) |
View |
| 2025-02-04 Sale |
2025-02-12 4:05 pm |
HilleVax Inc. | HLVX | Maltbie Shane Chief Financial Officer |
8,291 | $1.8233 | $15,117 | 79,887 (Direct) |
View |
| 2024-05-20 Sale |
2024-05-22 5:40 pm |
HilleVax Inc. | HLVX | Kohli Aditya Director |
18,000 | $14.79 | $266,291 | 764,878 (Direct) |
View |
| 2024-05-01 Sale |
2024-05-03 7:12 pm |
HilleVax Inc. | HLVX | Kohli Aditya Director |
6,898 | $14.03 | $96,770 | 782,878 (Direct) |
View |
| 2024-04-04 Purchase |
2024-04-08 4:22 pm |
HilleVax Inc. | HLVX | Frazier Life Sciences X L.P. FHMLS X L.P. FHMLS X L.L.C. Topper James N Heron Patrick J 10% Owner |
8,850 | $14.5 | $128,325 | 8,544,187 (Direct) |
View |
| 2024-04-03 Sale |
2024-04-05 5:48 pm |
HilleVax Inc. | HLVX | Kohli Aditya Director |
18,000 | $14.69 | $264,467 | 789,776 (Direct) |
View |
| 2024-03-28 Purchase |
2024-04-01 4:08 pm |
HilleVax Inc. | HLVX | McLoughlin Sean Chief Operating Officer |
1,250 | $16.98 | $21,225 | 1,250 (Direct) |
View |
| 2024-03-18 Sale(M) |
2024-03-20 6:27 pm |
HilleVax Inc. | HLVX | Kohli Aditya Director |
18,000 | $9.1253 | $164,256 | 807,776 (Direct) |
View |
| 2024-03-06 Sale |
2024-03-08 6:38 pm |
HilleVax Inc. | HLVX | Kohli Aditya Director |
18,000 | $18.66 | $335,872 | 825,776 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-22 5:20 pm |
HilleVax Inc. | HLVX | Kohli Aditya Director |
18,000 | $14.95 | $269,078 | 843,776 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-14 4:22 pm |
HilleVax Inc. | HLVX | Kohli Aditya Director |
6,000 | $15.32 | $91,921 | 861,776 (Direct) |
View |
| 2024-02-08 Sale |
2024-02-12 8:06 pm |
HilleVax Inc. | HLVX | Kohli Aditya Director |
8,866 | $14.93 | $132,383 | 939,276 (Direct) |
View |
| 2024-02-08 Sale |
2024-02-12 7:51 pm |
HilleVax Inc. | HLVX | Maltbie Shane Chief Financial Officer |
3,576 | $14.93 | $53,395 | 150,072 (Direct) |
View |
| 2024-02-08 Sale |
2024-02-12 7:47 pm |
HilleVax Inc. | HLVX | HERSHBERG ROBERT See Remarks |
11,597 | $14.93 | $173,161 | 1,354,918 (Direct) |
View |
| 2024-02-08 Sale |
2024-02-12 7:35 pm |
HilleVax Inc. | HLVX | Borkowski Astrid Chief Medical Officer |
3,933 | $14.93 | $58,726 | 284,744 (Direct) |
View |
| 2023-12-15 Sale |
2023-12-18 5:34 pm |
HilleVax Inc. | HLVX | Borkowski Astrid Chief Medical Officer |
10,000 | $15.5 | $155,000 | 165,193 (Direct) |
View |
| 2023-12-01 Sale |
2023-12-05 4:52 pm |
HilleVax Inc. | HLVX | Borkowski Astrid Chief Medical Officer |
20,000 | $14.35 | $287,000 | 175,193 (Direct) |
View |
| 2023-11-17 Sale |
2023-11-20 4:53 pm |
HilleVax Inc. | HLVX | Borkowski Astrid Chief Medical Officer |
10,000 | $14 | $140,000 | 195,193 (Direct) |
View |
| 2023-11-08 Sale |
2023-11-13 5:25 pm |
HilleVax Inc. | HLVX | Borkowski Astrid Chief Medical Officer |
5,000 | $13 | $65,000 | 205,193 (Direct) |
View |
| 2023-06-21 Sale |
2023-06-23 10:09 am |
HilleVax Inc. | HLVX | Borkowski Astrid Chief Medical Officer |
10,000 | $16.11 | $161,100 | 210,193 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-08 Option Award |
2024-02-12 8:06 pm |
N/A 2034-02-07 |
HilleVax Inc. | HLVX | Kohli Aditya Director |
126,398 | $0 | 939,276 (Direct) |
View |
| 2024-02-08 Option Award |
2024-02-12 7:51 pm |
N/A 2034-02-07 |
HilleVax Inc. | HLVX | Maltbie Shane Chief Financial Officer |
109,416 | $0 | 150,072 (Direct) |
View |
| 2024-02-08 Option Award |
2024-02-12 7:47 pm |
N/A 2034-02-07 |
HilleVax Inc. | HLVX | HERSHBERG ROBERT See Remarks |
401,087 | $0 | 1,354,918 (Direct) |
View |
| 2024-02-08 Option Award |
2024-02-12 7:35 pm |
N/A 2034-02-07 |
HilleVax Inc. | HLVX | Borkowski Astrid Chief Medical Officer |
123,484 | $0 | 284,744 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:05 pm |
N/A 2034-01-30 |
HilleVax Inc. | HLVX | McLoughlin Sean Chief Operating Officer |
250,000 | $0 | 250,000 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 6:44 pm |
N/A 2033-06-06 |
HilleVax Inc. | HLVX | Chu Shelley Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 6:41 pm |
N/A 2033-06-06 |
HilleVax Inc. | HLVX | Cocero Nanette Director |
11,000 | $0 | 11,000 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 6:41 pm |
N/A 2033-06-06 |
HilleVax Inc. | HLVX | Gerberding Julie L. Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 6:38 pm |
N/A 2033-06-06 |
HilleVax Inc. | HLVX | Sepulveda Jaime Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 6:36 pm |
N/A 2033-06-06 |
HilleVax Inc. | HLVX | HILLEMAN JERYL L Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 6:33 pm |
N/A 2033-06-06 |
HilleVax Inc. | HLVX | Heron Patrick J Director 10% Owner |
22,500 | $0 | 22,500 (Direct) |
View |
| 2023-05-08 Option Award |
2023-05-10 5:41 pm |
N/A 2033-05-07 |
HilleVax Inc. | HLVX | Cocero Nanette Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:22 pm |
N/A 2033-01-31 |
HilleVax Inc. | HLVX | Borkowski Astrid Chief Medical Officer |
128,333 | $0 | 296,774 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:21 pm |
N/A 2033-01-31 |
HilleVax Inc. | HLVX | Kohli Aditya Chief Operating Officer |
213,666 | $0 | 949,944 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:17 pm |
N/A 2033-01-31 |
HilleVax Inc. | HLVX | HERSHBERG ROBERT President and CEO |
569,916 | $0 | 1,347,378 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:16 pm |
N/A 2033-01-31 |
HilleVax Inc. | HLVX | Maltbie Shane Chief Financial Officer |
108,333 | $0 | 109,232 (Direct) |
View |
Ownership |
2023-01-10 5:00 pm |
N/A N/A |
HilleVax Inc. | HLVX | Maltbie Shane Chief Financial Officer |
0 | $0 | 110,164 (Direct) |
View |
| 2022-11-30 Exercise |
2022-12-01 5:47 pm |
2022-05-03 2031-07-02 |
HilleVax Inc. | HLVX | TAKEDA PHARMACEUTICAL CO LTD Takeda Vaccines Inc. 10% Owner |
5,883,500 | $0 | 6,724,000 (Indirect) |
View |
| 2022-08-19 Option Award |
2022-08-23 4:36 pm |
N/A 2032-08-18 |
HilleVax Inc. | HLVX | Gerberding Julie L. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-08-19 Option Award |
2022-08-23 4:35 pm |
N/A 2032-08-18 |
HilleVax Inc. | HLVX | Silbermann Susan Michele Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-08-19 Option Award |
2022-08-23 4:35 pm |
N/A 2032-08-18 |
HilleVax Inc. | HLVX | Chu Shelley Director |
25,000 | $0 | 25,000 (Direct) |
View |